secwatch.observer — SEC 8-K summary
======================================

Issuer:     Harvard Apparatus Regenerative Technology, Inc. (HRGN)
CIK:        0001563665
Form:       8-K
Filed at:   2021-09-08T23:59:59+00:00
Accession:  0001104659-21-113653
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biostage raises $2.6M in private placements, appoints Jerry He to board
-----------------------------------------------------------------------

- Raised $2.0M in Sept 2021 from DST Capital and An Zhang in private placement of 1M shares and warrants for 500K shares at $2.00 per unit.
- Combined with $0.6M from earlier placements in May/June 2021, total cash infusion of $2.6M.
- Proceeds expected to fund operations and capex into Q4 2021.
- Appointed Jerry He (Executive Vice Chairman of Bright Scholar) as Class I independent director; options worth $25K + annual cash fees $20K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1563665/000110465921113653/0001104659-21-113653-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1563665/000110465921113653/tm2127127d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-113653

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer